Vida Therapeutics Inc. logo
Portfolio company

Vida Therapeutics Inc.

Details
Region
Prairies and West
Industry sector
Biotechnology
Investment year
2012
Fund
Diversified Portfolio
Learn more
Lead
Dominique Bélanger - Managing partner, co-investments at BDC
Dominique Bélanger

Managing Partner

View profile
About the company

viDA Therapeutics is advancing first-in-class drugs based on inhibitors of the extracellular serine protease, Granzyme B, to treat autoimmune and chronic inflammatory diseases. The company is focused on advancing their lead candidate into the clinic.

Your privacy

BDC uses cookies to improve your experience on its website and for advertising purposes, to offer you products or services that are relevant to you. By clicking ῝I understand῎ or by continuing to browse this site, you consent to their use.

To find out more, consult our Policy on confidentiality.